Prostate News: - Bone Drug Reduces Fractures In Men Having Hormone Therapy For Prostate Cancer
Bone Drug Reduces Fractures In Men Having Hormone Therapy For Prostate Cancer
Drugmaker Amgen Inc announced yesterday, Monday, that a large trial of its bone drug denosumab increased bone density and cut fractures in men with non-metastatic prostate cancer who were having hormone blocking therapy. A side effect of androgen deprivation therapy (ADT), which stops the male hormones feeding the cancer, is weaker bones and increased risk of fracture.
Lawmakers probe FDA approval of Ranbaxy drugs
WASHINGTON (Reuters) - Two leading U.S. Democrats said on Tuesday they are investigating whether Food and Drug Administration knowingly allowed the sale of Ranbaxy drugs that may have been backed by fraudulent data.
Drinks industry facing tough laws
Ministers tell the drinks industry it must act more responsibly or face new laws governing the sale of alcohol.
Foreign-born TB cases need better control, US says (AP)
AP - Tuberculosis cases continue to fall in the United States, but some immigrants have disturbingly high rates of the disease, according to a study released Tuesday that called for more aggressive action.
Prostate Cancer Therapy May Not Help
Title: Prostate Cancer Therapy May Not Help
Category: Health News
Created: 7/9/2008
Last Editorial Review: 7/9/2008